Increased release of interleukin-12p40 in MS
- 1 September 1998
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 51 (3) , 753-758
- https://doi.org/10.1212/wnl.51.3.753
Abstract
Objective: The p40 subunit of interleukin (IL)-12 was recently demonstrated in active lesions in MS. We tested whether the p40 subunit of IL-12 can also be detected in CSF and serum of patients with this disease and, if so, whether release is associated with inflammatory disease activity. Results: This study demonstrates an increased (up to 1,000-fold) compartmentalized release of the p40 subunit but not of the heterodimer p70 in MS. Release of IL-12p40 correlated with classic markers of CNS inflammation (CSF cell counts, immunoglobulin G index) and was significantly increased in patients with gadolinium-enhancing plaques on MRI. Moreover, release of IL-12p40 was associated with CSF levels of myelin basic protein as a measure of myelin degradation. Conclusion: These results suggest a role of IL-12p40 in the pathophysiology of MS.Keywords
This publication has 12 references indexed in Scilit:
- The continuing saga of complement receptor type 3 (CR3)Journal of Clinical Investigation, 1996
- Molecular alterations in the aging immune system.The Journal of Experimental Medicine, 1995
- MHC research: fast forwardImmunology Today, 1993
- The calcium-binding protein calreticulin is a major constituent of lytic granules in cytolytic T lymphocytes.The Journal of Experimental Medicine, 1993
- Fetal liver T cell receptor gamma/delta+ T cells as cytotoxic T lymphocytes specific for maternal alloantigens.The Journal of Experimental Medicine, 1992
- On the production of neurologists in the United StatesNeurology, 1991
- DIENCEPHALIC AMNESIABrain, 1990
- How One Thing has Led to AnotherAnnual Review of Immunology, 1989
- An evaluation of ambulatory, cassette EEG monitoringNeurology, 1983
- The pathophysiology of brain ischemiaAnnals of Neurology, 1983